Scholarlink

<p>Bromazepam (BMZ) is a pharmaceutical drug of the benzodiazepine (BZD) class, commonly prescribed for its sedative, hypnotic, anxiolytic, and muscle relaxant properties. This medication has a higher abuse potential than other BZDs due to its rapid onset of action, moderate liposolubility, and pronounced anxiolytic effect mediated by the positive modulation of GABA<sub>A</sub> receptors. BMZ can be found in different aquatic matrices, mainly associated with sewage, industrial effluents, and surface waters, causing adverse effects on non-target species. Therefore, assessing whether BMZ causes biological effects at environmentally relevant concentrations in zebrafish, an important experimental model for the ecotoxicological assessment of pharmaceuticals, is crucial. Here, we assessed the effects of BMZ exposure during early development (3–120 hpf) at concentrations of 0, 7, 15 (a concentration detected in effluent samples), and 30&#xa0;μg L<sup>−1</sup> on survival, hatching, spontaneous movement, heart rate, locomotor activity, anxiety-like behavior, anti-predatory response, and antioxidant enzyme activity (catalase and superoxide dismutase). Exposure to BMZ decreased spontaneous movement (<i>p</i> = 0.0123), increased heart rate (<i>p</i> &lt; 0.0001), altered locomotor behavior, and reduced the activity of antioxidant enzymes (catalase, <i>p</i> = 0.0408; superoxide dismutase, <i>p</i> = 0.0109) compared to the control group in zebrafish larvae. In this study, we demonstrate that BMZ exposure impairs the early development of zebrafish, affecting physiological, behavioral, and biochemical parameters that may reduce individual fitness and compromise survival, growth, and predator escape, highlighting the ecological risks posed by BMZ residues in contaminated aquatic environments.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bromazepam exposure alters early development, behavior, and induces oxidative stress in zebrafish

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月16日

查看全文
  • Flavia Bernardo Chagas,
  • Aline Pompermaier,
  • Wagner Antonio Tamagno,
  • Carla Alves,
  • Suzana Fatima Bazoti,
  • Arielle Cristina Fornari,
  • Jennifer L. Freeman,
  • Magali Kemmerich,
  • Paulo Afonso Hartmann,
  • Marilia Hartmann

摘要

Bromazepam (BMZ) is a pharmaceutical drug of the benzodiazepine (BZD) class, commonly prescribed for its sedative, hypnotic, anxiolytic, and muscle relaxant properties. This medication has a higher abuse potential than other BZDs due to its rapid onset of action, moderate liposolubility, and pronounced anxiolytic effect mediated by the positive modulation of GABAA receptors. BMZ can be found in different aquatic matrices, mainly associated with sewage, industrial effluents, and surface waters, causing adverse effects on non-target species. Therefore, assessing whether BMZ causes biological effects at environmentally relevant concentrations in zebrafish, an important experimental model for the ecotoxicological assessment of pharmaceuticals, is crucial. Here, we assessed the effects of BMZ exposure during early development (3–120 hpf) at concentrations of 0, 7, 15 (a concentration detected in effluent samples), and 30 μg L−1 on survival, hatching, spontaneous movement, heart rate, locomotor activity, anxiety-like behavior, anti-predatory response, and antioxidant enzyme activity (catalase and superoxide dismutase). Exposure to BMZ decreased spontaneous movement (p = 0.0123), increased heart rate (p < 0.0001), altered locomotor behavior, and reduced the activity of antioxidant enzymes (catalase, p = 0.0408; superoxide dismutase, p = 0.0109) compared to the control group in zebrafish larvae. In this study, we demonstrate that BMZ exposure impairs the early development of zebrafish, affecting physiological, behavioral, and biochemical parameters that may reduce individual fitness and compromise survival, growth, and predator escape, highlighting the ecological risks posed by BMZ residues in contaminated aquatic environments.